Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 16 de 16
Filtrer
1.
J Hum Hypertens ; 36(1): 24-31, 2022 01.
Article de Anglais | MEDLINE | ID: mdl-34453103

RÉSUMÉ

Transduction of muscle sympathetic nerve activity (MSNA) into vascular tone varies with age and sex. Older normotensive men have reduced sympathetic transduction so that a given level of MSNA causes less arteriole vasoconstriction. Whether sympathetic transduction is altered in hypertension (HTN) is not known. We investigated whether sympathetic transduction is impaired in untreated hypertensive men compared to normotensive controls. Eight untreated hypertensive men and 10 normotensive men (age 50 ± 15 years vs. 45 ± 12 years (mean ± SD); p = 0.19, body mass index (BMI) 24.7 ± 2.7 kg/m2 vs. 26.0 ± 4.2 kg/m2; p = 0.21) were recruited. MSNA was recorded from the peroneal nerve using microneurography; beat-to-beat blood pressure (BP; Finapres) and heart rate (ECG) were recorded simultaneously at rest for 10 min. Sympathetic-transduction was quantified using a previously described method. The relationship between MSNA burst area and subsequent diastolic BP was measured for each participant with the slope of the regression indicating sympathetic transduction. MSNA was higher in the hypertensive group compared to normotensives (73 ± 17 bursts/100 heartbeats vs. 49 ± 19 bursts/100 heart bursts; p = 0.007). Sympathetic-transduction was lower in the hypertensive versus normotensive group (0.04%/mmHg/s vs. 0.11%/mmHg/s, respectively; R = 0.622; p = 0.006). In summary, hypertensive men had lower sympathetic transduction compared to normotensive individuals suggesting that higher levels of MSNA are needed to cause the same level of vasoconstrictor tone.


Sujet(s)
Hypertension artérielle , Système nerveux sympathique , Adulte , Sujet âgé , Pression sanguine/physiologie , Indice de masse corporelle , Rythme cardiaque/physiologie , Humains , Hypertension artérielle/diagnostic , Mâle , Adulte d'âge moyen , Muscles squelettiques/vascularisation , Muscles squelettiques/innervation , Système nerveux sympathique/physiologie
2.
Eur Radiol ; 30(7): 3890-3899, 2020 Jul.
Article de Anglais | MEDLINE | ID: mdl-32157411

RÉSUMÉ

OBJECTIVES: To use multi-parametric magnetic resonance imaging (MRI) to test the hypothesis that hypertensives would have higher retrograde venous blood flow (RVBF) in the internal jugular veins (IJV) vs. normotensives, and that this would inversely correlate with arterial inflow and gray matter, white matter, and cerebrospinal fluid volumes. METHODS: Following local institutional review board approval and written consent, a prospective observational 3-T MRI study of 42 hypertensive patients (53 ± 2 years, BMI 28.2 ± 0.6 kg/m2, ambulatory daytime systolic BP 148 ± 2 mmHg, ambulatory daytime diastolic BP 101 ± 2 mmHg) and 35 normotensive patients (48 ± 2 years, BMI 25.2 ± 0.8 kg/m2, ambulatory daytime systolic BP 119 ± 3 mmHg, ambulatory daytime diastolic BP 90 ± 2 mmHg) was performed. Phase contrast imaging calculated percentage retrograde venous blood flow (%RVBF), brain segmentation estimated regional brain volumes from 3D T1-weighted images, and pseudo-continuous arterial spin labeling measured regional cerebral blood perfusion. Statistical analysis included two-sample equal variance Student's T tests, two-way analysis of variance with Tukey's post hoc correction, and permutation-based two-group general linear modeling (p < 0.05). RESULTS: In the left IJV, %RVBF was higher in hypertensives (6.1 ± 1.5%) vs. normotensives (1.1 ± 0.3%, p = 0.003). In hypertensives, there was an inverse relationship of %RVBF (permutation-based general linear modeling) to cerebral blood flow in several brain regions, including the left occipital pole and the cerebellar vermis (p < 0.01). Percentage retrograde flow in the left IJV correlated inversely with the total matter volume (gray plus white matter volume) in hypertensives (r = - 0.49, p = 0.004). CONCLUSION: RVBF in the left IJV is greater in hypertensives vs. normotensives and is linked to regional hypoperfusion and brain total matter volume. KEY POINTS: • Hypertensive humans have higher retrograde cerebral venous blood flow, associated with regional brain hypoperfusion and lower tissue volume, compared with controls. • Cerebral retrograde venous blood flow may add further stress to already hypoperfused tissue in hypertensive patients. • The amount of retrograde venous blood flow in hypertensive patients may predict which patients might be at higher risk of developing cerebral pathologies.


Sujet(s)
Artères cérébrales/physiopathologie , Hypertension artérielle/physiopathologie , Veines jugulaires/imagerie diagnostique , Veines jugulaires/physiopathologie , Imagerie par résonance magnétique/méthodes , Circulation cérébrovasculaire/physiologie , Femelle , Humains , Imagerie tridimensionnelle , Mâle , Adulte d'âge moyen , Études prospectives , Marqueurs de spin
3.
Eur Radiol ; 29(3): 1574-1585, 2019 Mar.
Article de Anglais | MEDLINE | ID: mdl-30232515

RÉSUMÉ

OBJECTIVES: Left atrial enlargement (LAE) predicts cardiovascular morbidity and mortality. Impaired LA function also confers poor prognosis. This study aimed to determine whether left ventricular (LV) interstitial fibrosis is associated with LAE and LA impairment in systemic hypertension. METHODS: Following informed written consent, a prospective observational study of 86 hypertensive patients (49 ± 15 years, 53% male, office SBP 168 ± 30 mmHg, office DBP 97 ± 4 mmHg) and 20 normotensive controls (48 ± 13 years, 55% male, office SBP 130 ± 13 mmHg, office DBP 80 ± 11 mmHg) at 1.5-T cardiovascular magnetic resonance was conducted. Extracellular volume fraction (ECV) was calculated by T1-mapping. LA volume (LAV) was measured with biplane area-length method. LA reservoir, conduit and pump function were calculated with the phasic volumetric method. RESULTS: Indexed LAV correlated with indexed LV mass (R = 0.376, p < 0.0001) and ECV (R = 0.359, p = 0.001). However, ECV was the strongest significant predictor of LAE in multivariate regression analysis (odds ratio [95th confidence interval] 1.24 [1.04-1.48], p = 0.017). Indexed myocardial interstitial volume was associated with significant reductions in LA reservoir (R = -0.437, p < 0.0001) and conduit (R = -0.316, p = 0.003) but not pump (R = -0.167, p = 0.125) function. Multiple linear regression, correcting for age, gender, BMI, BP and diabetes, showed an independent decrease of 3.5% LA total emptying fraction for each 10 ml/m2 increase in myocardial interstitial volume (standard ß coefficient -3.54, p = 0.002). CONCLUSIONS: LV extracellular expansion is associated with LAE and impaired LA reservoir and conduit function. Future studies should identify if targeting diffuse LV fibrosis is beneficial in reverse remodelling of LA structural and functional pathological abnormalities in hypertension. KEY POINTS: • Left atrial enlargement (LAE) and impairment are markers of adverse prognosis in systemic hypertension but their pathophysiology is poorly understood. • Left ventricular extracellular volume fraction was the strongest independent multivariate predictor of LAE and was associated with impaired left atrial reservoir and conduit function. • LV interstitial expansion may play a central role in the pathophysiology of adverse atrioventricular interaction in systemic hypertension.


Sujet(s)
Volume cardiaque/physiologie , Atrium du coeur/physiopathologie , Ventricules cardiaques/physiopathologie , Hypertension artérielle/physiopathologie , Adulte , Sujet âgé , Femelle , Fibrose/anatomopathologie , Atrium du coeur/imagerie diagnostique , Atrium du coeur/anatomopathologie , Ventricules cardiaques/imagerie diagnostique , Ventricules cardiaques/anatomopathologie , Humains , Hypertension artérielle/imagerie diagnostique , Hypertension artérielle/anatomopathologie , Imagerie par résonance magnétique , Mâle , Adulte d'âge moyen , Études prospectives
4.
J Clin Hypertens (Greenwich) ; 20(4): 784-793, 2018 04.
Article de Anglais | MEDLINE | ID: mdl-29517128

RÉSUMÉ

We investigate the impact of dipper status on cardiac structure with cardiovascular magnetic resonance (CMR). Ambulatory blood pressure monitoring and 1.5T CMR were performed in 99 tertiary hypertension clinic patients. Subgroup analysis by extreme dipper (n = 9), dipper (n = 39), non-dipper (n = 35) and reverse dipper (n = 16) status was performed, matched in age, gender and BMI. Left ventricular (LV) mass was significantly higher for extreme dippers than dippers after correction for covariates (100 ± 6 g/m2 vs 79 ± 3 g/m2 , P = .004). Amongst extreme dippers and dippers (n = 48), indexed LV mass correlated positively with the extent of nocturnal blood pressure dipping (R = .403, P = .005). On post-hoc ANCOVA, the percentage of nocturnal dip had significant effect on indexed LV mass (P = .008), but overall SBP did not (P = .348). In the tertiary setting, we found a larger nocturnal BP drop was associated with more LV hypertrophy. If confirmed in larger studies, this may have implications on nocturnal dosing of anti-hypertensive medications.


Sujet(s)
Hypertension artérielle/physiopathologie , Hypertrophie ventriculaire gauche/imagerie diagnostique , Adulte , Sujet âgé , Antihypertenseurs/usage thérapeutique , Surveillance ambulatoire de la pression artérielle , Rythme circadien , Femelle , Humains , Hypertension artérielle/traitement médicamenteux , IRM dynamique , Mâle , Adulte d'âge moyen , Études prospectives
6.
Eur Heart J Cardiovasc Imaging ; 18(4): 441-450, 2017 Apr 01.
Article de Anglais | MEDLINE | ID: mdl-27334442

RÉSUMÉ

AIMS: In hypertension, the presence of left ventricular (LV) strain pattern on 12-lead electrocardiogram (ECG) carries adverse cardiovascular prognosis. The underlying mechanisms are poorly understood. We investigated whether hypertensive ECG strain is associated with myocardial interstitial fibrosis and impaired myocardial strain, assessed by multi-parametric cardiac magnetic resonance (CMR). METHODS AND RESULTS: A total of 100 hypertensive patients [50 ± 14 years, male: 58%, office systolic blood pressure (SBP): 170 ± 30 mmHg, office diastolic blood pressure (DBP): 97 ± 14 mmHg) underwent ECG and 1.5T CMR and were compared with 25 normotensive controls (46 ± 14 years, 60% male, SBP: 124 ± 8 mmHg, DBP: 76 ± 7 mmHg). Native T1 and extracellular volume fraction (ECV) were calculated with the modified look-locker inversion-recovery sequence. Myocardial strain values were estimated with voxel-tracking software. ECG strain (n = 20) was associated with significantly higher indexed LV mass (LVM) (119 ± 32 vs. 80 ± 17 g/m2, P < 0.05) and ECV (30 ± 4 vs. 27 ± 3%, P < 0.05) compared with hypertensive subjects without ECG strain (n = 80). ECG strain subjects had significantly impaired circumferential strain compared with hypertensive subjects without ECG strain and controls (-15.2 ± 4.7 vs. -17.0 ± 3.3 vs. -17.3 ± 2.4%, P < 0.05, respectively). In subgroup analysis, comparing ECG strain subjects to hypertensive subjects with elevated LVM but no ECG strain, a significantly higher ECV (30 ± 4 vs. 28 ± 3%, P < 0.05) was still observed. Indexed LVM was the only variable independently associated with ECG strain in multivariate logistic regression analysis [odds ratio (95th confidence interval): 1.07 (1.02-1.12), P < 0.05). CONCLUSION: In hypertension, ECG strain is a marker of advanced LVH associated with increased interstitial fibrosis and associated with significant myocardial circumferential strain impairment.


Sujet(s)
Électrocardiographie/méthodes , Hypertension artérielle/épidémiologie , Hypertrophie ventriculaire gauche/imagerie diagnostique , Hypertrophie ventriculaire gauche/épidémiologie , IRM dynamique/méthodes , Adulte , Études cas-témoins , Comorbidité , Produits de contraste , Femelle , Fibrose/imagerie diagnostique , Fibrose/anatomopathologie , Gadolinium , Humains , Hypertension artérielle/diagnostic , Mâle , Adulte d'âge moyen , Myocarde/anatomopathologie , Pronostic , Études rétrospectives , Indice de gravité de la maladie
7.
J Clin Hypertens (Greenwich) ; 19(1): 13-22, 2017 01.
Article de Anglais | MEDLINE | ID: mdl-27759186

RÉSUMÉ

European guidelines recommend that patients with hypertension be assessed for asymptomatic organ damage and secondary causes. The authors propose that a single magnetic resonance imaging (MRI) scan can provide comprehensive first-line imaging of patients assessed via a specialist hypertension clinic. A total of 200 patients (56% male, aged 51±15 years, office BP 168±30/96±16 mm Hg) underwent MRI of the heart, kidneys, renal arteries, adrenals and aorta. Comparisons were made with other imaging modalities where available. A total of 61% had left ventricular hypertrophy (LVH), 14% had reduced ejection fraction, and 15 patients had myocardial infarcts. Echocardiography overdiagnosed LVH in 15% of patients and missed LVH in 14%. Secondary causes were identified in 14.5% of patients: 12 adrenal masses, 10 renal artery stenoses, seven thyroid abnormalities, one aortic coarctation, one enlarged pituitary gland, one polycystic kidney disease, and one renal coloboma syndrome. This comprehensive MRI protocol is an effective method of screening for asymptomatic organ damage and secondary causes of hypertension.


Sujet(s)
Hypertension artérielle/complications , Hypertension artérielle/imagerie diagnostique , Imagerie par résonance magnétique/méthodes , Sujet âgé , Coarctation aortique/imagerie diagnostique , Coarctation aortique/épidémiologie , Colobome/imagerie diagnostique , Colobome/épidémiologie , Femelle , Humains , Hypertrophie ventriculaire gauche/imagerie diagnostique , Hypertrophie ventriculaire gauche/épidémiologie , Mâle , Adulte d'âge moyen , Infarctus du myocarde/imagerie diagnostique , Infarctus du myocarde/épidémiologie , Hypophyse/imagerie diagnostique , Hypophyse/anatomopathologie , Polykystoses rénales/imagerie diagnostique , Polykystoses rénales/épidémiologie , Occlusion artérielle rénale/imagerie diagnostique , Occlusion artérielle rénale/épidémiologie , Insuffisance rénale/imagerie diagnostique , Insuffisance rénale/épidémiologie , Études rétrospectives , Sensibilité et spécificité , Débit systolique , Reflux vésico-urétéral/imagerie diagnostique , Reflux vésico-urétéral/épidémiologie
8.
JACC Basic Transl Sci ; 1(5): 313-324, 2016 Aug.
Article de Anglais | MEDLINE | ID: mdl-27766316

RÉSUMÉ

Animal and human data indicate pathological afferent signaling emanating from the carotid body that drives sympathetically mediated elevations in blood pressure in conditions of hypertension. This first-in-man, proof-of-principle study tested the safety and feasibility of unilateral carotid body resection in 15 patients with drug-resistant hypertension. The procedure proved to be safe and feasible. Overall, no change in blood pressure was found. However, 8 patients showed significant reductions in ambulatory blood pressure coinciding with decreases in sympathetic activity. The carotid body may be a novel target for treating an identifiable subpopulation of humans with hypertension.

9.
Circ Res ; 119(12): e140-e151, 2016 Dec 09.
Article de Anglais | MEDLINE | ID: mdl-27672161

RÉSUMÉ

RATIONALE: Data from animal models of hypertension indicate that high blood pressure may develop as a vital mechanism to maintain adequate blood flow to the brain. We propose that congenital vascular variants of the posterior cerebral circulation and cerebral hypoperfusion could partially explain the pathogenesis of essential hypertension, which remains enigmatic in 95% of patients. OBJECTIVE: To evaluate the role of the cerebral circulation in the pathophysiology of hypertension. METHODS AND RESULTS: We completed a series of retrospective and mechanistic case-control magnetic resonance imaging and physiological studies in normotensive and hypertensive humans (n=259). Interestingly, in humans with hypertension, we report a higher prevalence of congenital cerebrovascular variants; vertebral artery hypoplasia, and an incomplete posterior circle of Willis, which were coupled with increased cerebral vascular resistance, reduced cerebral blood flow, and a higher incidence of lacunar type infarcts. Causally, cerebral vascular resistance was elevated before the onset of hypertension and elevated sympathetic nerve activity (n=126). Interestingly, untreated hypertensive patients (n=20) had a cerebral blood flow similar to age-matched controls (n=28). However, participants receiving antihypertensive therapy (with blood pressure controlled below target levels) had reduced cerebral perfusion (n=19). Finally, elevated cerebral vascular resistance was a predictor of hypertension, suggesting that it may be a novel prognostic or diagnostic marker (n=126). CONCLUSIONS: Our data indicate that congenital cerebrovascular variants in the posterior circulation and the associated cerebral hypoperfusion may be a factor in triggering hypertension. Therefore, lowering blood pressure may worsen cerebral perfusion in susceptible individuals.


Sujet(s)
Encéphale/imagerie diagnostique , Encéphale/physiologie , Circulation cérébrovasculaire/physiologie , Hypertension artérielle/imagerie diagnostique , Hypertension artérielle/physiopathologie , Adulte , Encéphale/vascularisation , Études cas-témoins , Études transversales , Hypertension essentielle , Femelle , Humains , Imagerie par résonance magnétique/méthodes , Mâle , Adulte d'âge moyen , Études rétrospectives , Résistance vasculaire/physiologie
10.
Nat Med ; 22(10): 1151-1159, 2016 10.
Article de Anglais | MEDLINE | ID: mdl-27595323

RÉSUMÉ

In view of the high proportion of individuals with resistance to antihypertensive medication and/or poor compliance or tolerance of this medication, new drugs to treat hypertension are urgently needed. Here we show that peripheral chemoreceptors generate aberrant signaling that contributes to high blood pressure in hypertension. We discovered that purinergic receptor P2X3 (P2rx3, also known as P2x3) mRNA expression is upregulated substantially in chemoreceptive petrosal sensory neurons in rats with hypertension. These neurons generate both tonic drive and hyperreflexia in hypertensive (but not normotensive) rats, and both phenomena are normalized by the blockade of P2X3 receptors. Antagonism of P2X3 receptors also reduces arterial pressure and basal sympathetic activity and normalizes carotid body hyperreflexia in conscious rats with hypertension; no effect was observed in rats without hypertension. We verified P2X3 receptor expression in human carotid bodies and observed hyperactivity of carotid bodies in individuals with hypertension. These data support the identification of the P2X3 receptor as a potential new target for the control of human hypertension.


Sujet(s)
Pression sanguine/génétique , Glomus carotidien/métabolisme , Cellules chimioréceptrices/métabolisme , ARN messager/métabolisme , Récepteurs purinergiques P2X3/génétique , Animaux , Pression sanguine/effets des médicaments et des substances chimiques , Glomus carotidien/cytologie , Hypertension artérielle/traitement médicamenteux , Hypertension artérielle/génétique , Mâle , Techniques de patch-clamp , Antagonistes des récepteurs purinergiques P2X/pharmacologie , Rats , Rats de lignée SHR , Rat Wistar , Réflexes anormaux/génétique , Cellules réceptrices sensorielles/effets des médicaments et des substances chimiques , Cellules réceptrices sensorielles/métabolisme
11.
J Clin Hypertens (Greenwich) ; 18(11): 1119-1127, 2016 11.
Article de Anglais | MEDLINE | ID: mdl-27316563

RÉSUMÉ

Hypertensive heart disease is often associated with a preserved left ventricular ejection fraction despite impaired myocardial shortening. The authors investigated this paradox in 55 hypertensive patients (52±13 years, 58% male) and 32 age- and sex-matched normotensive control patients (49±11 years, 56% male) who underwent cardiac magnetic resonance imaging at 1.5T. Long-axis shortening (R=0.62), midwall fractional shortening (R=0.68), and radial strain (R=0.48) all decreased (P<.001) as end-diastolic wall thickness increased. However, absolute wall thickening (defined as end-systolic minus end-diastolic wall thickness) was maintained, despite the reduced myocardial shortening. Absolute wall thickening correlated with ejection fraction (R=0.70, P<.0001). In multiple linear regression analysis, increasing wall thickness by 1 mm independently increased ejection fraction by 3.43 percentage points (adjusted ß-coefficient: 3.43 [2.60-4.26], P<.0001). Increasing end-diastolic wall thickness augments ejection fraction through preservation of absolute wall thickening. Left ventricular ejection fraction should not be used in patients with hypertensive heart disease without correction for degree of hypertrophy.


Sujet(s)
Cardiopathies/physiopathologie , Ventricules cardiaques/physiopathologie , Hypertension artérielle/physiopathologie , Adulte , Sujet âgé , Femelle , Humains , Imagerie par résonance magnétique , Mâle , Adulte d'âge moyen , Débit systolique , Fonction ventriculaire gauche
12.
Heart ; 102(20): 1671-9, 2016 10 15.
Article de Anglais | MEDLINE | ID: mdl-27260191

RÉSUMÉ

OBJECTIVE: Myocardial intracellular/extracellular structure and aortic function were assessed among hypertensive left ventricular (LV) phenotypes using cardiovascular magnetic resonance (CMR). METHODS: An observational study from consecutive tertiary hypertension clinic patients referred for CMR (1.5 T) was performed. Four LV phenotypes were defined: (1) normal with normal indexed LV mass (LVM) and LVM to volume ratio (M/V), (2) concentric remodelling with normal LVM but elevated M/V, (3) concentric LV hypertrophy (LVH) with elevated LVM but normal indexed end-diastolic volume (EDV) or (4) eccentric LVH with elevated LVM and EDV. Extracellular volume fraction was measured using T1-mapping. Circumferential strain was calculated by voxel-tracking. Aortic distensibility was derived from high-resolution aortic cines and contemporaneous blood pressure measurements. RESULTS: 88 hypertensive patients (49±14 years, 57% men, systolic blood pressure (SBP): 167±30 mm Hg, diastolic blood pressure (DBP): 96±14 mm Hg) were compared with 29 age-matched/sex-matched controls (47±14 years, 59% men, SBP: 128±12 mm Hg, DBP: 79±10 mm Hg). LVH resulted from increased myocardial cell volume (eccentric LVH: 78±19 mL/m(2) vs concentric LVH: 73±15 mL/m(2) vs concentric remodelling: 55±9 mL/m(2), p<0.05, respectively) and interstitial fibrosis (eccentric LVH: 33±10 mL/m(2) vs concentric LVH: 30±10 mL/m(2) vs concentricremodelling: 19±2 mL/m(2), p<0.05, respectively). LVH had worst circumferential impairment (eccentric LVH: -12.8±4.6% vs concentric LVH: -15.5±3.1% vs concentric remodelling: -17.1±3.2%, p<0.05, respectively). Concentric remodelling was associated with reduced aortic distensibility, but not with large intracellular/interstitial expansion or myocardial dysfunction versus controls. CONCLUSIONS: Myocardial interstitial fibrosis varies across hypertensive LV phenotypes with functional consequences. Eccentric LVH has the most fibrosis and systolic impairment. Concentric remodelling is only associated with abnormal aortic function. Understanding these differences may help tailor future antihypertensive treatments.


Sujet(s)
Hypertension artérielle/complications , Hypertrophie ventriculaire gauche/imagerie diagnostique , IRM dynamique , Myocarde/anatomopathologie , Dysfonction ventriculaire gauche/imagerie diagnostique , Fonction ventriculaire gauche , Adulte , Sujet âgé , Études cas-témoins , Angleterre , Femelle , Fibrose , Humains , Hypertension artérielle/diagnostic , Hypertrophie ventriculaire gauche/étiologie , Hypertrophie ventriculaire gauche/anatomopathologie , Hypertrophie ventriculaire gauche/physiopathologie , Mâle , Adulte d'âge moyen , Contraction myocardique , Services de consultations externes des hôpitaux , Phénotype , Valeur prédictive des tests , Centres de soins tertiaires , Dysfonction ventriculaire gauche/étiologie , Dysfonction ventriculaire gauche/anatomopathologie , Dysfonction ventriculaire gauche/physiopathologie , Remodelage ventriculaire
13.
J Clin Hypertens (Greenwich) ; 18(6): 585-92, 2016 06.
Article de Anglais | MEDLINE | ID: mdl-26857092

RÉSUMÉ

Renal denervation (RDN) is a therapy that targets treatment-resistant hypertension (TRH). The Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity) HTN-1 and Symplicity HTN-2 trials reported response rates of >80%; however, sham-controlled Symplicity HTN-3 failed to reach its primary blood pressure (BP) outcome. The authors address the current controversies surrounding RDN, illustrated with real-world data from two centers in the United Kingdom. In this cohort, 52% of patients responded to RDN, with a 13±32 mm Hg reduction in office systolic BP (SBP) at 6 months (n=29, P=.03). Baseline office SBP and number of ablations correlated with office SBP reduction (R=-0.47, P=.01; R=-0.56, P=.002). RDN appears to be an effective treatment for some patients with TRH; however, individual responses are highly variable. Selecting patients for RDN is challenging, with only 10% (33 of 321) of the screened patients eligible for the study. Medication alterations and nonadherence confound outcomes. Adequate ablation is critical and should impact future catheter design/training. Markers of procedural success and improved patient selection parameters remain key research aims.


Sujet(s)
Hypertension artérielle/thérapie , Rein/innervation , Sympathectomie/méthodes , Adulte , Sujet âgé , Antihypertenseurs/usage thérapeutique , Mesure de la pression artérielle , Essais cliniques comme sujet , Femelle , Humains , Hypertension artérielle/traitement médicamenteux , Hypertension artérielle/physiopathologie , Rein/chirurgie , Mâle , Adhésion au traitement médicamenteux , Adulte d'âge moyen , Résultat thérapeutique , Royaume-Uni
14.
Am J Kidney Dis ; 67(4): 548-58, 2016 Apr.
Article de Anglais | MEDLINE | ID: mdl-26763385

RÉSUMÉ

The UK-based National Institute for Health and Care Excellence (NICE) has updated its guidance on iron deficiency and anemia management in chronic kidney disease. This report outlines the recommendations regarding iron deficiency and their rationale. Serum ferritin alone or transferrin saturation alone are no longer recommended as diagnostic tests to assess iron deficiency. Red blood cell markers (percentage hypochromic red blood cells, reticulocyte hemoglobin content, or reticulocyte hemoglobin equivalent) are better than ferritin level alone at predicting responsiveness to intravenous iron. When red blood cell markers are not available, a combination of transferrin saturation < 20% and ferritin level < 100ng/mL is an alternative. In comparisons of the cost-effectiveness of different iron status testing and treatment strategies, using percentage hypochromic red blood cells > 6% was the most cost-effective strategy for both hemodialysis and nonhemodialysis patients. A trial of oral iron replacement is recommended in people not receiving an erythropoiesis-stimulating agent (ESA) and not on hemodialysis therapy. For children receiving ESAs, but not treated by hemodialysis, oral iron should be considered. In adults and children receiving ESAs and/or on hemodialysis therapy, intravenous iron should be offered. When giving intravenous iron, high-dose low-frequency administration is recommended. For all children and for adults receiving in-center hemodialysis, low-dose high-frequency administration may be more appropriate.


Sujet(s)
Anémie par carence en fer/diagnostic , Anémie par carence en fer/thérapie , Guides de bonnes pratiques cliniques comme sujet , Anémie par carence en fer/étiologie , Érythropoïétine/physiologie , Humains , Fer/physiologie , Méta-analyse comme sujet , Insuffisance rénale chronique/complications
15.
Curr Hypertens Rep ; 16(11): 493, 2014 Nov.
Article de Anglais | MEDLINE | ID: mdl-25236853

RÉSUMÉ

Hypertension is a leading risk factor for the development of several cardiovascular diseases. As the global prevalence of hypertension increases, so too has the recognition of resistant hypertension. Whilst figures vary, the proportion of hypertensive patients that are resistant to multiple drug therapies have been reported to be as high as 16.4 %. Resistant hypertension is typically associated with elevated sympathetic activity and abnormal homeostatic reflex control and is termed neurogenic hypertension because of its presumed central autonomic nervous system origin. This resistance to conventional pharmacological treatment has stimulated a plethora of medical devices to be investigated for use in hypertension, with varying degrees of success. In this review, we discuss a new therapy for drug-resistant hypertension, deep brain stimulation. The utility of deep brain stimulation in resistant hypertension was first discovered in patients with concurrent neuropathic pain, where it lowered blood pressure and improved baroreflex sensitivity. The most promising central target for stimulation is the ventrolateral periaqueductal gray, which has been well characterised in animal studies as a control centre for autonomic outflow. In this review, we will discuss the promise and potential mechanisms of deep brain stimulation in the treatment of severe, resistant hypertension.


Sujet(s)
Système nerveux autonome/physiopathologie , Stimulation cérébrale profonde , Hypertension artérielle/thérapie , Système nerveux sympathique/physiopathologie , Animaux , Pression sanguine , Humains , Hypertension artérielle/physiopathologie
16.
Hypertension ; 62(3): 533-41, 2013 Sep.
Article de Anglais | MEDLINE | ID: mdl-23817496

RÉSUMÉ

Renal denervation has shown promise in the treatment of resistant hypertension, although the mechanisms underlying the blood pressure (BP) reduction remain unclear. In a translational study of spontaneously hypertensive rats (n=7, surgical denervation) and resistant hypertensive human patients (n=8; 5 men, 33-71 years), we examined the relationship among changes in BP, sympathetic nerve activity, and cardiac and sympathetic baroreflex function after renal denervation. In humans, mean systolic BP (SBP; sphygmomanometry) and muscle sympathetic nerve activity (microneurography) were unchanged at 1 and 6 months after renal denervation (P<0.05). Interestingly, 4 of 8 patients showed a 10% decrease in SBP at 6 months, but sympathetic activity did not necessarily change in parallel with SBP. In contrast, all rats showed significant and immediate decreases in telemetric SBP and lumbar sympathetic activity (P<0.05), 7 days after denervation. Despite no change in SBP, human cardiac and sympathetic baroreflex function (sequence and threshold techniques) showed improvements at 1 and 6 months after denervation, particularly through increased sympathetic baroreflex sensitivity to falling BP. This was mirrored in spontaneously hypertensive rats; cardiac and sympathetic baroreflex sensitivity (spontaneous sequence and the Oxford technique) improved 7 days after denervation. The more consistent results in rats may be because of a more complete (>90% reduction in renal norepinephrine content) denervation. We conclude that (1) renal denervation improves BP in some patients, but sympathetic activity does not always change in parallel, and (2) baroreflex sensitivity is consistently improved in animals and humans, even when SBP has not decreased. Determining procedural success will be crucial in advancing this treatment modality.


Sujet(s)
Baroréflexe/physiologie , Pression sanguine/physiologie , Dénervation/méthodes , Hypertension artérielle/physiopathologie , Rein/innervation , Adulte , Sujet âgé , Animaux , Femelle , Rythme cardiaque/physiologie , Humains , Hypertension artérielle/chirurgie , Rein/physiopathologie , Mâle , Adulte d'âge moyen , Rats
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE